Pacer Advisors Inc. increased its position in shares of Ventas, Inc. (NYSE:VTR – Free Report) by 17.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 47,772 shares of the real estate investment trust’s stock after acquiring an additional 7,153 shares during the quarter. Pacer Advisors Inc.’s holdings in Ventas were worth $3,697,000 at the end of the most recent quarter.
Several other hedge funds have also added to or reduced their stakes in VTR. MV Capital Management Inc. bought a new stake in Ventas during the 4th quarter worth about $45,000. Compound Planning Inc. grew its position in shares of Ventas by 8.7% during the 4th quarter. Compound Planning Inc. now owns 5,537 shares of the real estate investment trust’s stock worth $428,000 after buying an additional 442 shares during the period. Mercer Global Advisors Inc. ADV grew its position in shares of Ventas by 48.5% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 102,446 shares of the real estate investment trust’s stock worth $8,249,000 after buying an additional 33,438 shares during the period. EP Wealth Advisors LLC bought a new stake in shares of Ventas during the fourth quarter worth approximately $905,000. Finally, Mackenzie Financial Corp raised its stake in shares of Ventas by 160.7% during the fourth quarter. Mackenzie Financial Corp now owns 583,476 shares of the real estate investment trust’s stock worth $45,917,000 after buying an additional 359,697 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.
Insider Activity
In other Ventas news, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the transaction, the director directly owned 28,349 shares in the company, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler bought 2,500 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The stock was acquired at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the purchase, the director owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their position. The SEC filing for this purchase provides additional information. Insiders own 0.53% of the company’s stock.
Ventas Stock Up 1.6%
Ventas (NYSE:VTR – Get Free Report) last posted its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.01). The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. Ventas had a return on equity of 2.09% and a net margin of 4.25%.The company’s revenue for the quarter was up 22.0% on a year-over-year basis. During the same quarter last year, the business posted $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Analysts expect that Ventas, Inc. will post 3.88 EPS for the current year.
Ventas Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 16th. Investors of record on Tuesday, June 30th will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend is Tuesday, June 30th. Ventas’s dividend payout ratio (DPR) is presently 378.18%.
Analysts Set New Price Targets
A number of brokerages have issued reports on VTR. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Ventas in a research note on Friday, March 27th. Raymond James Financial began coverage on shares of Ventas in a research report on Tuesday, June 16th. They set an “outperform” rating and a $94.00 target price for the company. BMO Capital Markets reissued an “outperform” rating and issued a $100.00 price target on shares of Ventas in a research note on Monday, May 4th. Jefferies Financial Group raised their price target on Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Finally, JPMorgan Chase & Co. upped their price objective on Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Monday, May 11th. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $96.00.
Get Our Latest Stock Report on Ventas
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
See Also
- Five stocks we like better than Ventas
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
